Enhancement of Public, Private and Faith Based Laboratory Capacity to Support HIV/AIDS Prevention, Care and Treatment in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH12 123705CONT17

Opportunity Information: Apply for CDC RFA GH12 123705CONT17

This funding opportunity, titled "Enhancement of Public, Private and Faith Based Laboratory Capacity to Support HIV/AIDS Prevention, Care and Treatment in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. government grant announcement focused on strengthening laboratory systems that support HIV/AIDS services in Tanzania. It sits within PEPFAR, the U.S. global initiative aimed at controlling the HIV epidemic through expanded prevention, diagnosis, treatment, and care. The core idea behind the opportunity is that reliable, accessible laboratory testing is a backbone of effective HIV programming, because everything from timely diagnosis to treatment monitoring and quality patient management depends on lab capacity that is consistent, accurate, and well coordinated across different types of health facilities.

The opportunity is issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically under CDC's Center for Global Health (CGH). It is listed as a health-related funding activity (FundingActivityCategory: Health) and is associated with CFDA number 93.067, which corresponds to CDC global health assistance activities. The award mechanism is a Cooperative Agreement, which is important because it usually means CDC expects to have substantial programmatic involvement, such as providing technical direction, collaborating on implementation approaches, and monitoring performance against agreed targets. In practice, cooperative agreements tend to involve closer collaboration with the funding agency than a standard grant, especially for large, complex health system strengthening work like laboratory networks and national quality systems.

This announcement is categorized as "Continuation" funding (OpportunityCategory: Continuation). That label typically signals it is not a brand-new open competition designed to bring many new organizations into the portfolio, but rather an extension or follow-on to an existing project or recipient arrangement. The posting lists an expected number of awards of one, which reinforces the sense that the funding is likely intended for a specific ongoing partner or a very limited set of eligible entities, rather than broad, open competition. The "AwardCeiling" field is shown as 0, which often appears in federal listings when the specific maximum amount is not published in the synopsis or is determined through a separate process such as an approved continuation budget; it does not necessarily mean no funding is available, but rather that the ceiling is not specified in the posted summary.

The eligibility field is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)." Without the missing eligibility narrative, the safe interpretation is that eligibility may be restricted or defined by additional criteria not captured in the abbreviated data, which is common for continuation awards. Sometimes continuation announcements limit applications to current recipients, specific categories of organizations, or entities that meet particular partnership conditions in-country. Because the opportunity explicitly references public, private, and faith-based laboratories, it indicates the program scope includes multiple laboratory ownership and management models, aiming for a harmonized national approach rather than improvements confined only to government facilities.

In terms of what the funded work is meant to accomplish, the stated purpose is to enhance laboratory capacity across Tanzania in support of HIV/AIDS prevention, care, and treatment. That objective usually includes strengthening the laboratory network to deliver reliable HIV-related diagnostic and monitoring services, improving quality management systems so that test results are accurate and comparable across sites, expanding access to key tests that inform clinical decisions, and building the workforce, infrastructure, and supply systems needed to keep labs functioning sustainably. It also commonly involves strengthening linkages between laboratories and clinical services so that results get to clinicians and patients quickly, supporting continuity of care and reducing loss to follow-up. When framed under PEPFAR, the laboratory improvements are typically aligned with national HIV strategies and with global targets for diagnosing people living with HIV, initiating effective treatment, and maintaining viral suppression, all of which depend on functional testing and reporting systems.

The timeline included in the listing shows a creation date of October 12, 2016, with an original closing date of December 12, 2016. That roughly two-month application window is consistent with many federal notices, and in a continuation context it often reflects a structured process where the incumbent recipient prepares a continuation application or work plan for the next budget period. The opportunity number is "CDC RFA GH12 123705CONT17," which also hints at its continuation nature: "RFA" indicates a Request for Applications, "GH" suggests global health, and "CONT" generally signals continuation, potentially tied to a specific project year or internal tracking cycle.

Overall, the grant opportunity is a CDC/PEPFAR-supported cooperative agreement intended to maintain or expand an ongoing effort to strengthen Tanzania's laboratory capacity across public, private, and faith-based sectors, with the ultimate goal of improving the effectiveness and reliability of HIV prevention, diagnosis, treatment monitoring, and patient care. It is structured as a continuation award with a single anticipated recipient, emphasizing sustained implementation and close technical partnership with CDC rather than a wide-open competition among many new applicants.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Enhancement of Public, Private and Faith Based Laboratory Capacity to Support HIV/AIDS Prevention, Care and Treatment in the United Republic of Tanzania under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 12, 2016.
• Applicants must submit their applications by Dec 12, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH12 123705CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: